Abstract
Bipolar disorders are recurrent disturbances in mood that include periods both of depression and mania. Classic bipolar disorders, with manic episodes lasting for at least several days, often start in adolescence, but are uncommon in earlier childhood. Treatment of mania in young patients should include ensuring the individual's safety, and administration of a mood-stabilizing drug, or, in severe cases, a neuroleptic. Prophylaxis with lithium or an anticonvulsant should then be considered. In younger children, brief outbursts of excessive emotion—especially anger—should be recognized as a notable clinical problem. These outbursts do not necessarily constitute the beginnings of a classic bipolar disorder, but should trigger a diagnostic differential that also includes attention-deficit hyperactivity disorder, reaction to hostile environments, severe mood dysregulation, substance misuse, and autism spectrum disorders.
Key Points
-
Bipolar disorders in children and adolescents are characterized by a repetitive pattern of episodes of depression and mania that last for 1 day or more
-
The diagnosis of mania should be made with respect to developmentally appropriate standards of euphoria and grandiosity
-
Acute treatment of mania should include measures for the safety of the young person, and a mood-stabilizing drug, or, in severe and psychotic cases, a neuroleptic
-
Prophylaxis of future episodes with lithium or antiepileptic drugs should be considered
-
Frequent, brief outbursts of excessive emotion, especially anger, that are severe and cause impairment should be recognized as a notable clinical problem
-
Differential diagnosis of emotional outbursts should include attention-deficit hyperactivity disorder, reaction to hostile or upsetting environments, severe mood dysregulation, substance misuse, anxiety or depression, and bipolar disorder
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders® (DSM-IV®) 4th edn (American Psychiatric Association Publishing, Arlington, 1004).
Kowatch, R. A. et al. Treatment guidelines for children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry 44, 213–235 (2005).
Lewinsohn, P. M., Hops, H., Roberts, R. E., Seeley, J. R. & Andrews, J. A. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J. Abnorm. Psychol. 102, 133–144 (1993).
Lewinsohn, P. M., Rohde, P., Seeley, J. R., Klein, D. N. & Gotlib, I. H. Psychosocial functioning of young adults who have experienced and recovered from major depressive disorder during adolescence. J. Abnorm. Psychol. 112, 353–363 (2003).
Johnson, J. G., Cohen, P. & Brook, J. S. Associations between bipolar disorder and other psychiatric disorders during adolescence and early adulthood: a community based longitudinal investigation. Am. J. Psychiatry 157, 1679–1681 (2000).
Costello, E. J., Mustillo, S. & Erkanli, A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch. Gen. Psychiatry 60, 837–844 (2003).
Costello, E. J. et al. The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch. Gen. Psychiatry 53, 1129–1136 (1996).
Axelson, D. et al. Phenomenology of children and adolescents with bipolar spectrum disorders. Arch. Gen. Psychiatry 63, 1139–1148 (2006).
Birmaher, B. et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) Study. Am. J. Psychiatry 166, 795–804 (2009).
Geller, B. et al. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry 159, 927–933 (2002).
Geller, B. & Luby, J. Child and adolescent bipolar disorder: a review of the past 10 years. J. Am. Acad. Child Adolesc. Psychiatry 36, 1168–1176 (1997).
National Institute for Health and Clinical Excellence. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care [online], (2006).
Martin, A. et al. Age effects on antidepressant-induced manic conversion. Arch. Pediatr. Adolesc. Med. 158, 773–780 (2004).
Gracious, B. L., Youngstrom, E. A. & Findling, R. L. Discriminative validity of a parent version of the Young Mania Rating Scale. J. Am. Acad. Child Adolesc. Psychiatry 41, 1350–1359 (2002).
Youngstrom, E. A., Findling, R. L., Youngstrom, J. K. & Calabrese, J. R. Toward an evidence-based assessment of pediatric bipolar disorder. J. Clin. Child Adolesc. Psychol. 34, 433–448 (2005).
Geller, B., Williams, M., Zimerman, B. & Frazier, J. Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-UKSADS) (Washington University, St Louis, 1996).
Consoli, A., Deniau, E., Huynh, C., Purper, D. & Cohen, D. Treatments in child and adolescent bipolar disorders. Eur. Child Adolesc. Psychiatry 16, 187–198 (2007).
Geller, B. et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J. Am. Acad. Child Adolesc. Psychiatry 37, 171–178 (1998).
Kafantaris, V. et al. Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. J. Am. Acad. Child Adolesc. Psychiatry 43, 984–993 (2004).
Tohen, M. et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am. J. Psychiatry 164, 1547–1556 (2007).
Delbello, M. P., Schwiers, M. L., Rosenberg, H. L. & Strakowski, S. M. A doubleblind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J. Am. Acad. Child Adolesc. Psychiatry 41, 1216–1223 (2002).
Kafantaris, V., Coletti, D. J., Dicker, R., Padula, G. & Kane, J. M. Lithium treatment of acute mania in adolescents: a large open trial. J. Am. Acad. Child Adolesc. Psychiatry 42, 1038–1045 (2003).
Strober, M. et al. Early childhood attention deficit hyperactivity disorder predicts poorer response to acute lithium therapy in adolescent mania. J. Affect. Disord. 51, 145–151 (1998).
Findling, R. L. et al. Combination lithium and divalproex sodium in pediatric bipolarity. J. Am. Acad. Child Adolesc. Psychiatry 42, 895–901 (2003).
Deltito, J. A., Levitan, J., Damore, J., Hajal, F. & Zambenedetti, M. Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients. Acta Psychiatr. Scand. 97, 236–240 (1998).
Wagner, K. D. et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry 41, 1224–1230 (2002).
Kowatch, R. A., Sethuraman, G., Hume, J. H., Kromelis, M. & Weinberg, W. A. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol. Psychiatry 53, 978–984 (2003).
Frazier, J. A. et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. 11, 239–250 (2001).
Pavuluri, M. N. et al. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J. Affect. Disord. 82, 103–111 (2004).
Biederman, J. et al. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol. Psychiatry 58, 589–594 (2005).
Biederman, J. et al. A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. Bipolar Disord. 9, 888–894 (2007).
Barzman, D. H. et al. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. J. Child Adolesc. Psychopharmacol. 14, 593–600 (2004).
Bhangoo, R. K. et al. Medication use in children and adolescents treated in the community for bipolar disorder. J. Child Adolesc. Psychopharmacol. 13, 515–522 (2003).
Masi, G., Mucci, M. & Millepiedi, S. Clozapine in adolescent inpatients with acute mania. J. Child Adolesc. Psychopharmacol. 12, 93–99 (2002).
Hazell, P., O'Connell, D., Heathcotem, D., Robertson, J. & Henry, D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ 310, 897–901 (1995).
National Institute for Health and Clinical Excellence. Depression in children and young people: identification and management in primary, community and secondary care [online], (2005).
Usala, T., Clavenna, A., Zuddas, A. & Bonati, M. Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. Eur. Neuropsychopharmacol. 18, 62–73 (2008).
Brent, D. & Weersing, V. R. Depressive disorders in childhood and adolescence. In Rutter's Child and Adolescent Psychiatry, 5th edn (Eds Rutter, M. et al.) 587–612 (Blackwell Publishing, Oxford, 2008).
Belmaker, R. H. Treatment of bipolar depression. N. Engl. J. Med. 356, 1771–1773 (2007).
Gijsman, H. J., Geddes, J. R., Rendell, J. M., Nolen, W. A. & Goodwin, G. M. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am. J. Psychiatry 161, 1537–1547 (2004).
Sachs, G. S. et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J. Clin. Psychiatry 55, 391–393 (1994).
Nemeroff, C. B. et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am. J. Psychiatry 158, 906–912 (2001).
Thase, M. E. et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J. Clin. Psychopharmacol. 26, 600–609 (2006).
Calabrese, J. R. et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry 162, 1351–1360 (2005).
Miklowitz, D. et al. Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial. Arch. Gen. Psychiatry 65, 1053–1061 (2008).
Henry, C. A., Zamvil, L. S., Lam, C., Rosenquist, K. J. & Ghaemi, S. N. Long-term outcome with divalproex in children and adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. 13, 523–529 (2003).
Strober, M. et al. Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. J. Am. Acad. Child Adolesc. Psychiatry 34, 724–731 (1995).
Dailey, L. F., Townsend, S. W., Dysken, M. W. & Kuskowski, M. A. Recidivism in medication-noncompliant serious juvenile offenders with bipolar disorder. J. Clin. Psychiatry 66, 477–484 (2005).
Findling, R. L. et al. Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry 44, 409–417 (2005).
McIntyre, R. S., Mancini, D. A., McCann, S., Srinivasan, J. & Kennedy, S. H. Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord. 5, 28–35 (2003).
Stringaris, A. & Goodman, R. Mood lability and psychopathology in youth. Psychol. Med. 38, 1–9 (2008).
Geller, B. et al. Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling. J. Affect. Disord. 51, 81–91 (1998).
Geller, B. et al. Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J. Am. Acad. Child Adolesc. Psychiatry 39, 1543–1548 (2000).
Geller, B., Zimerman, B., Williams, M., Bolhofner, K. & Craney, J. L. Bipolar disorder at prospective follow-up of adults who had prepubertal major depression disorder. Am. J. Psychiatry 158, 125–127 (2001).
Geller, B. et al. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry 159, 927–933 (2002).
Geller, B. et al. Phenomenology and longitudinal course of children with a prepubertal and early adolescent bipolar disorder phenotype. In Bipolar Disorder in Childhood and Early Adolescence (Eds Geller, B. & Delbello, M. P.) 25–50 (Guilford Press, New York and London, 2003).
Biederman, J. et al. Further evidence of unique developmental phenotypic correlates of pediatric bipolar disorder: findings from a large sample of clinically referred preadolescent children assessed over the last 7 years. J. Affect. Disord. 82 (Suppl. 1), S45–S58 (2004).
Wozniak, J. et al. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J. Am. Acad. Child Adolesc. Psychiatry 34, 867–876 (1995).
Hammer, C., Bunge, D., Burney, E. & Adrian, C. Longitudinal study of diagnoses in children of women with unipolar and bipolar affective disorder. Arch. Gen. Psychiatry 47, 1112–1117 (1990).
Reddy, Y. C. & Srinath, S. Juvenile bipolar disorder. Acta Psychiatr. Scand. 102, 162–170 (2000).
Faraone, S. V., Biederman, J., Mennin, D., Wozniak, J. & Spencer, T. Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype? J. Am. Acad. Child Adolesc. Psychiatry 36, 1378–1390 (1997).
Taylor, E. & Sonuga-Barke, E. Disorders of attention and activity. In Rutter's Child and Adolescent Psychiatry, 5th edn (Eds Rutter, M. et al.) 521–542 (Blackwell Publishing, Oxford, 2008).
MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 56, 1073–1086 (1999).
Leibenluft, E. & Dickstein, D. P. Bipolar disorder in children and adolescents. In Rutter's Child and Adolescent Psychiatry, 5th edn (Eds Rutter, M. et al.) 613–627 (Blackwell Publishing, Oxford, 2008).
Caspi, A. et al. Role of genotype in the cycle of violence in maltreated children. Science 297, 851–854 (2002).
Hagino, O. R. et al. Untoward effects of lithium treatment in children aged four through six years. J. Am. Acad. Child Adolesc. Psychiatry 34, 1584–1590 (1995).
Frazier, J. A. et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. 11, 239–250 (2001).
Morgan, S. & Taylor, E. Editorial: antipsychotic drugs in children with autism. BMJ 334, 1069–1070 (2007).
Taylor, E. et al. European clinical guidelines for hyperkinetic disorder—first upgrade. Eur. Child Adolesc. Psychiatry 13 (Suppl. 1), I7–I30 (2004).
Scheffer, R. E., Kowatch, R. A., Carmody, T. & Rush, A. J. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am. J. Psychiatry 162, 58–64 (2005).
Woolfenden, S. R., Williams K. J. & Peat, J. Family and parenting interventions in children and adolescents with conduct disorder and delinquency aged 10–17 Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD003015. doi: 10.1002/14651858.CD003015 (2001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Taylor, E. Managing bipolar disorders in children and adolescents. Nat Rev Neurol 5, 484–491 (2009). https://doi.org/10.1038/nrneurol.2009.117
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2009.117
This article is cited by
-
Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis
Molecular Psychiatry (2016)
-
Clinical Staging in the Pathophysiology of Psychotic and Affective Disorders: Facilitation of Prognosis and Treatment
Neurotoxicity Research (2010)